Beta2 microglobulin: a surprising therapeutic target for prostate cancer and renal cell carcinoma.
Freeman
Michael R
MR
D017209:Apoptosis / Q000502:physiology; D002292:Carcinoma, Renal Cell / Q000378:metabolism*; D015972:Gene Expression Regulation, Neoplastic / Q000235:genetics / Q000502:physiology; D006801:Humans; D007680:Kidney Neoplasms / Q000378:metabolism*; D008297:Male; D011471:Prostatic Neoplasms / Q000378:metabolism* / Q000628:therapy*; D011994:Recombinant Proteins; D015398:Signal Transduction / Q000502:physiology*; D014407:Tumor Cells, Cultured; D001613:beta 2-Microglobulin / Q000502:physiology*
D011994:Recombinant Proteins; D001613:beta 2-Microglobulin